Oncology Information Systems Market Report 2026

Oncology Information Systems Market Overview

• Oncology Information Systems market size has reached to $3.26 billion in 2025 • Expected to grow to $5.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Cancer Prevalence Fuels Surge In Oncology Information Systems Market • Market Trend: The Rise Of Cloud-Based Solutions In Oncology Information Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oncology Information Systems Market?

Oncology information systems refer to a software solution that supports the provision of comprehensive information and image management for cancer. They are used to manage cancer data and monitor cancer care. The major products of oncology information systems are solutions and professional services. The solution refers to a collection of software applications and services those suppliers, channel partners, and value-added resellers offer to clients. Oncology information systems are used in several applications, such as medical oncology, radiation oncology, and surgical oncology. It is used by several end-users, such as hospitals and diagnostic imaging centers, ablation care centers, cancer care centers, government institutions, and research facilities.

What Is The Oncology Information Systems Market Growth Forecast?

The oncology information systems market size is expected to see strong growth in the next few years. It will grow to $5.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for precision oncology solutions, rising investments in digital healthcare infrastructure, expansion of tele-oncology services, growing focus on data-driven cancer treatment planning, increasing integration of imaging and analytics platforms. Major trends in the forecast period include increasing adoption of integrated oncology data platforms, rising use of ai-driven clinical decision support, growing deployment of cloud-based oncology information systems, expansion of interoperable cancer care solutions, enhanced focus on patient-centric data management.

What Is The Driver Of The Oncology Information Systems Market?

The increasing global prevalence of cancer is expected to propel the growth of the oncology information systems market. The prevalence of cancer refers to the number of people living with cancer. The oncology information system helps by streamlining data management and patient information and is used to monitor and document various aspects of cancer care and manage cancer data in hospitals. For instance, in January 2025, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported that 18.6 million are cancer survivors, with projections exceeding 22 million by 2035. Therefore, the increasing global prevalence of cancer is driving the growth of the oncology information systems industry.

Key Players In The Global Oncology Information Systems Market

Major companies operating in the oncology information systems market are Koninklijke Philips NV; Varian Medical Systems Inc.; McKesson Corporation; Siemens Medical Solutions USA Inc.; Elekta AB; Cerner Corporation; Flatiron Health Inc.; Accuray Incorporated; CureMD Corporation; RaySearch Laboratories; Optum Inc.; Allscripts Healthcare Solutions Inc.; athenahealth Inc.; Candelis Inc.; Carestream Health Inc.; Change Healthcare; Computer Programs and Systems Inc.; Epic Systems Corporation; GE Healthcare; IBM Corporation; Altos Solutions Inc.; Advanced Data Systems Corporation

Global Oncology Information Systems Market Trends and Insights

Major companies operating in the oncology information systems market are focusing on developing advanced solutions, such as integrated AI-assisted treatment planning, to enhance clinical decision-making, improve workflow efficiency, and optimize patient care. Integrated AI-assisted treatment planning refers to technological systems that combine artificial intelligence with oncology workflows to provide personalized treatment recommendations, streamline data management, and support multidisciplinary care teams. For instance, in June 2025, RaySearch Laboratories, a Sweden-based medical technology company, released RayCare v2025, the latest version of its oncology information system, featuring enhanced AI-driven tools for treatment planning, scheduling, and workflow automation. The system enables oncology centers to optimize patient pathways, reduce planning time, and improve coordination across radiotherapy and multidisciplinary teams. By leveraging AI and advanced workflow integration, this innovation supports more precise, efficient, and patient-centric cancer care delivery.

What Are Latest Mergers And Acquisitions In The Oncology Information Systems Market?

In August 2023, Exor NV, a Netherlands-based company, acquired Philips Healthcare for $2.8 billion. With this acquisition, Exor aims to expand its portfolio by incorporating Philips Healthcare's expertise in providing oncology information systems. Philips Healthcare NV is a Netherlands-based hospital that offers oncology information systems.

What Defines the Oncology Information Systems Market?

The oncology information systems market includes revenues earned by entities by providing clinical trial protocol management, drug inventory management, toxicity assessment, and survivorship care. The oncology information systems generally collect the data related to cancer treatment and care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncology Information Systems Market Report 2026?

The oncology information systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology information systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.